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Abstract
Background:  In the 1980s there was substantial interest in early pregnancy and pre-pregnancy
interventions to increase birth weight and reduce preterm birth. We developed an inter-pregnancy
intervention, implemented in a randomised controlled trial, to be provided by midwives at home soon
after women's first birth.
Methods: MCH nurses invited women to take part during their home visit to new mothers. Women's
contact details, with their permission, were passed to the study midwife. She had a randomisation schedule
to which women's names were added before she met the women or their partners. All women recruited
had a home visit from the study midwife with a discussion of their first pregnancy, labour and birth and
the postpartum experience. Women in the intervention arm received in addition a pre-pregnancy
intervention with discussion of social, health or lifestyle problems, preparation and timing for pregnancy,
family history, rubella immunisation, referrals for health problems, and a reminder card. The primary
outcome was defined as a birth weight difference in the second birth of 100 g (one-sided) in favour of the
intervention. Additional data collected were gestational age, perinatal deaths and birth defects. Analyses
used EPI-INFO and STATA.
Results:  Intervention and comparison groups were comparable on socioeconomic  factors, prior
reproductive history and first birth outcomes. Infant birth weight in the second birth was lower (-97.4 g,))
among infants in the intervention arm. There were no significant differences between intervention and
comparison arms in the proportion of women having a preterm birth, an infant with low birthweight, or
an infant with a birth weight <10th percentile. There were more adverse outcomes in the intervention arm:
ten births <32 weeks), compared with one in standard care, and more infants with a birth weight <2000
g, 16 compared with two in standard care
Conclusion: As the primary outcome was envisaged to be either improved birth weight or no effect, the
study was not designed to identify the alternative outcome with confidence. Despite widespread support
for pre-pregnancy interventions to improve maternal and perinatal health, this first randomised controlled
trial of a multi-component intervention provided at home, did not have a beneficial outcome.
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Background
At the time this project was initiated (1980–85) there was
substantial interest in the idea of pre-pregnancy – or pre-
conception – counselling and care. Pre-pregnancy care
was discussed in three contexts. The first was routine
advice, counselling and care around rubella immunisa-
tion, nutrition, smoking, alcohol consumption, and exer-
cise for all women, prior to conception and thus prior to
antenatal care [1,2] The second was provision of advice
and counselling on specific issues for women perceived to
have  increased risks of an adverse pregnancy outcome;
women with recurrent miscarriage, a prior perinatal
death, a prior infant with low birthweight or an infant
with a major birth defect [3]. The third was care of women
with known risks to the fetus or themselves from maternal
health problems such as diabetes, epilepsy, heart disease,
renal disease, or from indicated treatment [4].
The rationale, then and now, was that many factors affect-
ing fetal health and survival, or maternal health, are
present well before the first antenatal visit, often before
conception, limiting options for effective intervention in
pregnancy [5]. Other considerations were that assistance
and support for modifying behaviours such as smoking
might be more effective prior to pregnancy, given the
increased anxiety that may occur in early pregnancy.
Before assessment of gestational age by ultrasound scan-
ning became common, there were also concerns that a
'natural' cycle and a reliable date for the last menstrual
period needed to be re-established before conception;
thus women were advised to replace hormonal contracep-
tion or intrauterine devices with barrier methods for sev-
eral months before trying to conceive.
Pre-pregnancy Information and Counselling Service (PPIS)
The setting in which the trial was planned was a newly
established pre-pregnancy service (PPIS) in inner urban
Melbourne [6]. It was initiated by two obstetricians from
a University Department of Obstetrics and Gynaecology,
in association with a Community Health Centre, and
funded within a new, national, community health pro-
gramme. The primary role of the PPIS was to provide a
'universal' walk-in service locally, and a secondary school
health education component. It also accepted referrals
and provided a telephone information service. One full-
time, experienced, midwife, subsequently increased to 1.5
positions, staffed the PPIS, with support from the first
author. The PPIS self-referral and telephone service
attracted in the main well educated and socially advan-
taged women, who were not living in the locality. This
finding, together with the policy that evaluation was to
have a key role in services funded by the new community
health program, contributed to the development of the
pre-pregnancy intervention trial.
Objectives of the PPIS trial
1. To recruit women into a randomised trial of pre-preg-
nancy advice/counselling in a community setting where
mothers were at higher risk of a poor outcome. The three
local areas had substantial numbers of recent migrants,
refugees, single parents, families with a low income and
families in public housing
2. To assess the effectiveness of the intervention in terms
of the birthweight of the second child, as the most sensi-
tive single indicator of fetal wellbeing.
3. To incorporate the intervention, including data collec-
tion and follow-up, into the routine work of community
health nurses/midwives and Maternal and Child Health
Nurses (MCHN) to be able to assess the feasibility of
implementing the intervention more widely if it were
effective.
Local MCHNs were key partners in the trial. They pro-
vided a universal service funded by local government and
State government, from postnatal hospital discharge, at
that time more than five days after birth for the majority
of women, to school entry. In Victoria, all births are noti-
fied by the hospital of birth to the MCH Centre closest to
the woman's residence, with a statutory home visit by the
MCHN in the first week after hospital discharge. Over
95% of women attend the MCH Centre in the first six
months after birth [8]. Consultations were held with the
Director of Maternal and Child Health (Health Depart-
ment of Victoria), the Regional Infant Welfare Advisors,
Infant Welfare staff in municipalities close to the Commu-
nity Health Centre, the Administrator and Board of Man-
agement of the Community Health Centre, and the
Central Health Interpreter Service, in the planning phase.
At these meetings we discussed the trial rationale, the
intervention, planned recruitment and follow-up, seeking
input on how these could be incorporated into the stand-
ard working of each of the services. There was strong sup-
port for the proposed trial across all those consulted.
Methods
Design
The study design was a randomised controlled trial, with
individual randomisation. It was designed to be able to
identify a mean birth weight difference of ≥ 100 g in the
intervention arm. There was no Data Monitoring Com-
mittee and no stopping rules were defined.
Participants and recruitment procedures
All women attending local MCH Centres with their first
child were eligible for inclusion in the trial. Each MCHN
discussed the project briefly with all eligible women and
asked permission to give the PPIS midwife their contactBMC Public Health 2006, 6:299 http://www.biomedcentral.com/1471-2458/6/299
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details. The PPIS midwife collected women's names and
addresses weekly from the MCH nurses, and recorded
whether an interpreter would be needed, and for what
language. Women's names were then entered into the trial
logbook where the sequence of allocations (derived from
random number tables by the first author and utilising
balanced block randomisation in blocks of two, four or
six) was already listed. Thus allocation occurred before the
PPIS midwife had met the woman. The PPIS midwife con-
tacted women whose details had been provided and
arranged a home visit to confirm participation. There was
a Central Health Interpreter Service in Melbourne at that
time making it possible to book an interpreter for a spe-
cific language for the home visit, so that a significant pro-
portion of immigrant women could be included.
Recruitment began in May 1982 and ended in July 1991.
The timing of recruitment was in the early months after
the first birth, to ensure that the women's own health was
recognised as a key factor, as it has been in more recent
interventions [7]. Follow-up continued to the end of
1994.
The intervention
Comparison group
All women recruited received a home visit from the PPIS
midwife with a discussion of their first pregnancy, labour
and birth and the postpartum experience. Any questions
asked by the women were answered.
Intervention group
Women randomised to receive the intervention received a
pre-pregnancy health intervention that consisted of:
1. Identification of any current social, health or lifestyle
problems.
2. Discussion of timing, planning and preparation for the
next pregnancy
3. Offers of referral for any specific problem identified
(e.g. to a dietician, relaxation group, physiotherapist, fam-
ily planning clinic, general practitioner) all available at
the Community Health Centre or nearby, or at a local hos-
pital clinic; linkage with appropriate community
resources (e.g. language-specific play-group) and net-
works.
4. Taking a family/genetic history and arranging a referral
if necessary.
5. Arranging for rubella immunisation if not immune
6. Discussion of the points summarised on a WAIT, STOP,
and GO reminder card. The card was headed Signs to follow
before pregnancy, and designed to mimic traffic lights:
 WAIT (Orange)
• For 3 months after using the pill or loop
• For 3 months after German measles vaccination
• Until you really want another child
 STOP (Red)
• Cigarettes
• Alcohol
• Other over the counter drugs and medications
 Go (Green)
• To the doctor when you have missed two periods
• Regularly for antenatal checks
• Ring us if you have any questions or problems
The card included the name and address of the PPIS and
the telephone number.
The commonest issues raised by women in the interven-
tion arm at this time were choice of contraceptive method
(n = 274), the 'ideal' interval between children (262),
smoking (202), rubella (199), diet (177), operative birth
(175), alcohol (172), breastfeeding (170), sex since the
birth (166), caring for the baby (121), the decision to
have another child (102) and postnatal depression (76).
Sample size, primary outcome and secondary outcomes
The study was designed to identify a difference of ≥ 100 g
in the primary outcome – the mean birth weight of the
second children, in favour of the intervention arm of the
trial (α = 0.05, β = 0.80. one-sided), calculated as 394 in
each arm. Loss to follow-up was predicted to be at least
20%, making the total recruitment goal 950 women [9]
Secondary outcomes were gestational age at birth, preterm
birth grouped as 20–27 weeks, 28–31 weeks, and 32–36
weeks; low birth weight (<2,500 g), perinatal deaths and
birth defects. Birth weights less than the sex-specific 10th
percentile were added later. All twins were included in the
birth weight analysis [10]. They were excluded from birth
weight < 10th percentile as the standards for this categori-
sation were derived from singleton births only [11].
¾
¾
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Data collection and analysis
Information about the previous pregnancy and birth was
hand written on A5 cards at the first home visit by the
PPIS midwives, and updated at later contacts. Where pos-
sible, follow-up of the subsequent birth took place at a
planned home visit, but telephone and – letters were also
used, especially when women had moved outside the
local area. Most participants provided details for at least
one close relative as a secondary contact. When these
processes were inadequate, follow-up data on the out-
come of the second pregnancy and birth were sought from
the referring MCHN and, if the woman had moved to
another part of the State, from the MCHN in the new area.
Transfer of the data to computer did not occur until 1995.
EPI INFO [12] was used for data checking and cleaning.
Data analysis was carried out using EPI-INFO and STATA
version 8 [13]. Characteristics of the parents and the first
child were described and tabulated. Intervention and
comparison groups were compared in terms of the first
and second child's birth weight (mean and standard devi-
ation), the proportions of infants with low birth weight,
preterm birth and in preterm subgroups, and among sin-
gletons the proportions with a birth weight below the
10th percentile for gestational age and sex. Given the very
small number of infants who died or had birth anomalies
these are described in full but not formally compared.
One analysis that was not pre-specified but prompted by
study findings compared the time interval from the first
birth to the conception of the second infant in the two
arms of the trial.
Results
Table 1 shows the flow of participants through the trial:
1688 were approached, 109 refused (65 in the interven-
tion arm, 44 in standard care), and 1579 agreed to take
part. Many of those who refused were defined as de facto
refusals since they had agreed to take part, and provided
contact details, but did not keep appointments, were not
at home for up to three planned visits, behaved in a threat-
ening way – or their partner did – or refused entry to the
PPIS midwife. When participating women had their first
visit a further 11% were found to be ineligible (see Table
1). A further 84 had already moved out of the area at the
time of the first attempted contact, 63 were already preg-
nant and 29 already had two or more children, something
not known to the MCH service. More women from the
intervention arm (157) than in the standard care arm
(128) were lost or ineligible, leaving 1403 active partici-
pants. Women subsequently lost to the study were those
who decided not to have another child (n = 31), usually
for reasons of severe parental ill health; those who had not
had a second pregnancy by 1995 (222), and 364 who
were lost to follow-up. Fewer women were lost to follow-
up from the intervention arm (173) than from the stand-
ard care arm (191) at this stage making the final partici-
pants 392 in the intervention arm and 394 in the
comparison arm.
Table 1: Recruitment, refusals, eligibility, and later study losses
Recruitment, randomisation and losses Intervention Comparison
Women approached 842 846
Refused -65 -44
Agreed to participation, recruited and randomised 777 802
Ineligible post randomisation
Moved before 1st contact -44 -40
Pregnant before 1st contact -33 -30
Baby was a 2nd or later child -15 -14
Ineligible and/or refused prior to trial Total -92 Total -84
Eligible and consenting to participation 685 718
Subsequent loss to the study
Decision not to have another child -12 -19
No 2nd pregnancy by end 1994 -108 -114
Lost to follow-up -173 -191
Ineligible or lost to follow-up of those eligible and consenting Total -293 Total -324
Study completion 392 394BMC Public Health 2006, 6:299 http://www.biomedcentral.com/1471-2458/6/299
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The socio-demographic and past reproductive history
characteristics of the study families are summarised in
Table 2. The population recruited was typical of inner-
urban Melbourne at that time, in terms of the proportion
of women born outside Australia (more than a third), the
proportion born in a country where English was not the
primary language (a quarter), and the other countries of
birth most commonly represented (Vietnam and Greece).
The occupations of fathers were similar in the two arms
[14], as were the specific Local Government Areas of the
families' residence at recruitment. Prior reproductive
problems and mode of delivery at the first birth were also
similar in intervention and comparison groups. The two
groups did not differ in the duration of breastfeeding, the
type of contraception used, or the interval between the
intervention and the birth of the second child.
Table 3 summarises the perinatal outcomes of the first
births. The mean birth weights differed by only 39 g in
intervention and comparison arms and the standard devi-
ation was the same in both arms. The proportion with an
infant of low birth weight (<2,500 g) was similar in the
two arms, (5% and 4%). The proportion of infants with a
birth weight below the 10th percentile using sex-specific
tables was also similar (16% and 13%). The mean gesta-
tional age was identical in the two arms. There was a small
difference in rates of preterm birth, 6.5% in the interven-
tion and 4.6% in the comparison arm There were no dif-
ferences in very preterm births (<32 weeks gestation).
There were no perinatal deaths and no infants with major
birth anomalies among the participants' first births. The
infants included four sets of twins, one in the intervention
arm and three in the comparison arm.
Table 4 summarises the perinatal outcomes post-interven-
tion. At the second birth the primary outcome measure
was a significant difference in mean birth weight, but the
outcome was not in the predicted direction. Babies in the
intervention arm were lighter by 97 g. There were no sig-
nificant differences in mean gestational age, though the
standard error was larger in the intervention arm. The pro-
portion with a birth weight below the 10th percentile
using sex-specific tables did not differ significantly in the
two arms, being 11% in the intervention arm and 8% in
the comparison arms. There were more infants with birth
weights below 1500 g and below 2000 g in the interven-
tion arm, and a marked difference in births <32 weeks ges-
tation, with ten births in the intervention arm and one in
the comparison arm The second births included four sets
of twins, two in the intervention and two in the compari-
son arms.
There were seven known perinatal death among the sec-
ond births, four associated with birth defects and three
infants born extremely preterm, including one set of
twins. The perinatal mortality was 8.9/1000 births. The
perinatal mortality in the State of Victoria for 1983–92
was 8.8/1000 births [15]. Infants known to have birth
anomalies included two with anencephaly, one with
major multiple malformations (not specified), one with
multiple heart defects and an absent right kidney, one
with a ventricular septal defect, one with aniridia, one
with Hirschsprung's disease and one with a fetal heart
defect, not otherwise described, and congenital heart
block. Five infants with a birth anomaly were in the inter-
vention arm, two in the comparison arm, a combined
prevalence of 8.8/1000. In 1983–94 the overall preva-
lence of birth anomalies in singletons in Victoria, includ-
Table 2: Characteristics of the participants
Intervention: N = 392 Comparison: N = 394
Maternal age N%N%
<20 10 2.6 18 4.6
20–24 81 20.9 70 17.9
25–29 127 32.4 144 36.9
30–34 135 34.2 129 33.1
35–39 36 9.2 27 6.9
≥ 40 0 - 2 0.5
Missing data 3 - 4 -
Region of birth (Mother)
Australia 254 64.5 279 70.8
New Zealand/UK 23 5.9 13 3.3
Europe 28 7.1 24 6.1
Asia/Middle East 75 19.1 71 18.0
A f r i c a 61 . 541 . 0
America 5 1.3 3 0.8
Missing data 1 - 0 -
Occupation (Father)
Professional 16 4.1 14 3.6
Proprietor/Manager 24 6.1 15 3.8
Office and sales worker 89 22.7 111 28.2
Farmer 87 22.2 83 21.1
Skilled worker 60 15.3 53 13.5
Semiskilled worker 72 18.4 79 20.0
Unskilled worker 42 10.7 39 9.9
Missing data 2 - 0 -
Local Government area
A 181 46.1 190 48.2
B 120 30.6 112 28.4
C 6 61 6 . 87 21 8 . 3
Other 25 5.6 20 5.1
Prior problems
Infertility 31 7.9 36 9.1
Prior miscarriage ≥ 1 37 9.4 43 10.9
Prior termination ≥ 1 4 31 1 . 03 6 9 . 1
1st birth unplanned 105 26.8 115 29.2
1st birth unwanted 11 2.8 7 1.8
First birth
Spontaneous vaginal* 180 46.1 206 52.3
Forceps 118 30.0 115 29.2
V a c u u m 30 . 820 . 5
Elective caesarean 15 3.6 9 2.3
Emergency caesarean 48 12.3 40 10.2
Missing data 28 7.2 22 5.6
* includes 4 vaginal breech births in each armBMC Public Health 2006, 6:299 http://www.biomedcentral.com/1471-2458/6/299
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ing stillbirths and terminations of pregnancy for an
identified malformation was 3.1% [16].
An additional analysis prompted by the greater number of
very preterm births in the intervention arm identified a
shorter intervention to conception interval among very
preterm births in that arm. Their mean interval was 82
weeks (SD 37) compared with a mean of 103 weeks (SD
63) for all births in the intervention arm, and 101 weeks
(SD 64) for all births in the comparison arm.
Discussion
The PPIS trial was designed at the same time as a number
of other very different pregnancy interventions designed
to increase mean birth weight, and to reduce low birth
weight and preterm birth through the provision of social
support or enhanced nutrition [17-23]. None of the oth-
ers implemented their intervention package before preg-
nancy but most aimed to recruit women relatively early in
pregnancy. Four of these five trials and a recently reported
additional trial [24] identified unexpected adverse out-
comes, particularly extremely preterm births, or late ter-
minations of pregnancy, i.e. findings similar to those in
the PPIS trial. One factor which all of those trials had in
common was that the intervention was provided by some-
one who was not the usual provider of antenatal care. In
the one trial where there were no such unexpected adverse
outcomes the supportive intervention was provided at
home by midwives, a pattern within usual maternity care
in the UK, where the trial was carried out [17]. Midwives
provided the intervention in the PPIS trial at home but
this was not usual care in Australia.
Three hypotheses to explain the possible adverse out-
comes of the PPIS trial came out of discussions with col-
leagues in Australia and Canada. The first was that the
intervention itself might have heightened parental stress
and anxiety about perinatal outcomes, with stress and
anxiety contributing to very preterm birth [25,26]. The
second was that there might have been an increased risk
of conception at the extremes of the fertile period, giving
rise to unplanned conception or less than ideal implanta-
tion, if women and their partners had given up their usual
method of contraception for an alternative one. The
shorter intervention to conception interval associated
with the very preterm births in the intervention arm might
be a marker for this risk factor. The third hypothesis was
that if women and their partners took a very positive
approach to the full intervention package it might have
improved their overall health to a point where fetuses
Table 3: Perinatal outcomes of the 1st birth (pre-intervention)
Intervention N = 392 Comparison N = 394
Birth weight
Mean (SD), g 3296 (509) 3335 (504) Difference -39 g,
Missing data (3) (2)
Birth weight <10thpercentile* 43 (11%) 32 (8%) OR (exact) 1.39 [0.84,2.33]
Low Birth weight
<1000 g 0 0
1000–1499 1 2
1500–1999 4 4
2000–2499 14 11
All low birthweight 19 (4.9%) 17 (4.3%)
365 373
Missing data (8) (6)
All births 392 396
Gestation (weeks)
Mean (SD) 39.6 (1.7) 39.6 (1.7)
Preterm birth (<37 weeks) 25 (6.5%) 17 (4.6%) OR (exact) 1.14 (0.56–2.34)
Preterm birth
20–27 weeks 0 0
28–31 weeks 1 1
32–36 weeks 24 16
All preterm gestations 25 (6.5%) 17 (4.6%) 'OR 1.51(0.77. 2.98)
All with gestations ≥ 37 weeks 361 371
Missing data (6) (6)
All gestations 392 394
*All twins excludedBMC Public Health 2006, 6:299 http://www.biomedcentral.com/1471-2458/6/299
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with a birth anomaly or with poor placentation were actu-
ally sustained in utero for a longer period of time, with a
shift from miscarriage to very preterm birth.
Alternative explanations are that detailed discussions of
family health increased perceptions of risk, or led to diffi-
culties between the parents or difficulties with their fami-
lies of origin. Recommendations to stop smoking, alcohol
and over the counter drugs might have been another prob-
lematic piece of advice. It is also possible that the 'medi-
calisation' of such a human and family-focussed event as
pregnancy and birth was in itself harmful. We could not
totally rule out a contribution from selective participation
in the study at the initial home visit: 65 women in the
intervention arm, compared with 44 in standard care,
opted out of the study. Overall, there were no significant
differences in participation between the two arms.
Informed consent of participants was sought through the
three-fold process outlined in the Methods: discussion of
the trial by the MCHN, verbal agreement by the woman to
have her details given to the PPIS midwife and subsequent
contact by the midwife to make an appointment and fol-
low-up with a visit. Consent of the Community Health
Centre, and the Maternal and Child Health service was
based on a series of consultations held with each group,
before the trial was implemented to describe the study
and respond to queries, comments and criticisms. The
Community Health Centre did not have a Human
Research Ethics Committee and there was no equivalent
body at that time in the then Health Commission of Vic-
toria. When the project was awarded National Health and
Medical Research Council research funding to complete
the follow-up of second births (1992) we were required to
provide written information about the study to all subse-
quent participants and to seek formal Ethics approval by
the Board of the Community Health Centre. The Board
co-opted an Ethics Committee Member from one of the
nearby teaching hospitals to assist in this process.
Potential limitations of the intervention included the absence
of advice to take periconceptional folate. In 1981–2 there
was still marked disagreement about the benefits and risks
of vitamins and folate before conception and in the first
months of pregnancy. Publication of the proceedings of a
workshop held in late 1982 for experts involved in recent
or planned research on the prevention of neural tube
defects, discussed the available evidence and its shortcom-
Table 4: Perinatal outcomes of the 2nd birth (post-intervention)
Intervention N = 392 Comparison N = 394
Birth interval (months)
Mead (SD) 40.0 (30) 38.1 (26) F 0.89, p 0.35; unequal variance in birth interval
Missing (2) (1)
Birth weight
Mean (SD) 3403 (509) 3500 (504) Difference -97 g
Missing data (3) (2)
Low birth weight (<2500 g) 25/393 14/394 OR (exact) 1.85 [0.91, 3.91]
Birth weight <10thpercentile* 40/378 (11%) 31/382(8%) OR (exact) 1.14 [0.55, 2.38]
Low birth weight
<1000 g 6 0
1000–1499 3 0
1500–1999 7 2
2000–2499 9 12
All with birth weight (≥ 2,500 g 367 380
Missing data (3) (2)
All births 395 396
Gestation
Mean (SD) 39.3 (2.2) 39.5 (1.5)
Preterm birth (<37 weeks) 24 (6%) 17 (4%) OR (exact) 1.44 (0.73, 2.91)
Preterm birth
20–27 weeks 4 0
28–31 weeks 6 1
32–36 weeks 14 16
All with gestations ≥ 37 weeks 366 374
Missing data (2) (3)
All gestations 392 394
*All twins excluded.BMC Public Health 2006, 6:299 http://www.biomedcentral.com/1471-2458/6/299
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ings and we were influenced by the evident uncertainty
and disagreement [27]. By the time the four trials of peri-
conceptional supplementation were published [28-31]
recruitment to the PPIS trial was virtually complete.
Another potential limitation was the quality of the evi-
dence on the effect of alcohol use before pregnancy. Sev-
eral US papers had reported adverse effects on the fetus of
even extremely low maternal consumption of alcohol, in
early pregnancy or immediately prior to pregnancy, as
well as effects of paternal alcohol use around the time of
conception [32,33]. Despite the biological implausibility
of some of these effects and the relatively small numbers
of people in the studies we did advise stopping alcohol
consumption before and during pregnancy. Contempo-
rary population-based data on alcohol and tobacco use,
collected in early pregnancy in another Australian state
(Tasmania) did not show adverse effects of alcohol on
fetal growth or preterm birth until maternal consumption
was reported at more than two standard drinks a day [34],
a level of drinking reported by 0.4% of Tasmanian
women. Subsequent research in large cohorts has not con-
firmed the early US studies [35,36].
Limitations of the trial included slow recruitment. It
occurred at half the rate planned, extending the duration
of the trial and making it harder to maintain local interest
and Maternal and Child Health Nurses' enthusiasm.
Another factor slowing recruitment was staff turnover
[37]. A common work pattern at the time was moving to
a new position after two years, to get a broad experience
in community settings. Each new staff member needed a
familiarization and training period: many were unfamil-
iar with randomised trials at the time of recruitment.
A greater limitation was the research team's lack of recog-
nition that the women participating were of lower, rather
than higher risk of adverse pregnancy outcomes. The deci-
sion to recruit women through existing services for moth-
ers and infants failed to take into account the fact that
women who had adverse outcomes in their first preg-
nancy (a perinatal death, an infant with a major congeni-
tal anomaly or a very preterm infant) would be under-
represented. Mothers whose infants had died would not
be part of MCH services and mothers of infants requiring
on-going care from hospitals or specialist services were
likely to have been using those services, or visits to private
paediatricians, for routine health advice and support as an
alternative to their local MCHN. None of the first-born
infants included in the PPIS trial was born before 30
weeks gestation.
More than 50% of participants moved house before the
birth of their second child, making follow-up a much
larger part of the midwives' role than originally planned
[38]. The average interval between the first and second
births was a mean of 39 months compared with the pre-
dicted two years. This extended the time required for fol-
low-up and made follow-up more difficult.
Other pre-pregnancy interventions are sparse. A recent sys-
tematic review of preconception interventions [39] found
only one randomised trial [40] which used an opportun-
istic strategy, recruiting women who had a negative preg-
nancy test, explaining the trial, inviting participation, and
randomising by tossing a coin. All participants were given
a preconception risk survey. Although an average of over
eight risks per woman were identified, and more than half
the women made another visit to the service in the next
year, there was no difference between intervention and
usual care arms in the proportion of risks addressed. A
recently reported trial recruited women who had given
birth spontaneously before 34 weeks gestation, to be ran-
domised four months after that birth to receive either oral
azithromycin 1 g twice (4 days apart) plus 750 g of sus-
tained-release metronidazole daily for seven days, or iden-
tical – appearing placebos, repeated every 4 months until
the subsequent pregnancy. The intervention did not
reduce subsequent preterm birth with these authors also
concluding that the intervention might be associated with
a shorter gestational age and lower birth weight [41].
The PPIS study strengths are that it remains the only com-
pleted trial of a broad pre-pregnancy intervention. It dem-
onstrated that it was feasible to test a pre-pregnancy
intervention using a 'gold standard' design within socially
disadvantaged communities, including women on low
incomes and culturally diverse women, incorporating the
intervention into an existing population-wide service. It
provided a model for joint action between four commu-
nity health services. It also identified issues relevant to the
planning of future trials. Data on the high proportion of
participants who turned out to be ineligible or lost to the
study are likely to be relevant to other population based
pre-pregnancy interventions.
Conclusion
Despite wide-ranging support for pre-pregnancy interven-
tions to improve maternal and perinatal outcomes [42]
none of the published trials so far, nor this trial, has iden-
tified beneficial effects.
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Table 5: Reporting details for randomised trials
PAPER SECTION And topic Item Description Reported on Page #
TITLE & ABSTRACT 1 How participants were allocated to interventions (e.g., "random allocation", 
"randomized", or "randomly assigned").
4
INTRODUCTION Background 2 Scientific background and explanation of rationale. 3
METHODS Participants 3 Eligibility criteria for participants and the settings and locations where the data were 
collected.
3–4
Interventions 4 Precise details of the interventions intended for each group and how and when they 
were actually administered.
4–5
Objectives 5 Specific objectives and hypotheses. 4
Outcomes 6 Clearly defined primary and secondary outcome measures and, when applicable, any 
methods used to enhance the quality of measurements (e.g., multiple observations, 
training of assessors).
5
Sample size 7 How sample size was determined and, when applicable, explanation of any interim 
analyses and stopping rules.
5
Randomization – Sequence generation 8 Method used to generate the random allocation sequence, including details of any 
restrictions (e.g., blocking, stratification)
4–5
Randomization – Allocation concealment 9 Method used to implement the random allocation sequence (e.g., numbered containers 
or central telephone), clarifying whether the sequence was concealed until 
interventions were assigned.
4
Randomization – Implementation 10 Who generated the allocation sequence, who enrolled participants, and who assigned 
participants to their groups.
4–5
Blinding (masking) 11 Whether or not participants, those administering the interventions, and those assessing 
the outcomes were blinded to group assignment. When relevant, how the success of 
blinding was evaluated.
n/a
Statistical methods 12 Statistical methods used to compare groups for primary outcome(s); Methods for 
additional analyses, such as subgroup analyses and adjusted analyses.
6
RESULTS Participant flow 13 Flow of participants through each stage (a diagram is strongly recommended). 
Specifically, for each group report the numbers of participants randomly assigned, 
receiving intended treatment, completing the study protocol, and analyzed for the 
primary outcome. Describe protocol deviations from study as planned, together with 
reasons. n/a
7, 22, Table 1
Recruitment 14 Dates defining the periods of recruitment and follow-up. 8
Baseline data 15 Baseline demographic and clinical characteristics of each group. 6, Table 2
Numbers analyzed 16 Number of participants (denominator) in each group included in each analysis and 
whether the analysis was by "intention-to-treat". State the results in absolute numbers 
when feasible (e.g., 10/20, not 50%).
392 and 394, I-T-T
Outcomes and estimation 17 For each primary and secondary outcome, a summary of results for each group, and the 
estimated effect size and its precision (e.g., 95% confidence interval).
Tables 3 and 4
Ancillary analyses 18 Address multiplicity by reporting any other analyses performed, including subgroup 
analyses and adjusted analyses, indicating those pre-specified and those exploratory.
n/a
Adverse events 19 All important adverse events or side effects in each intervention group. 8
DISCUSSION Interpretation 20 Interpretation of the results, taking into account study hypotheses, sources of potential 
bias or imprecision and the dangers associated with multiplicity of analyses and 
outcomes.
8–10
Generalizability 21 Generalizability (external validity) of the trial findings. 9–10
Overall evidence 22 General interpretation of the results in the context of current evidence. 9–10BMC Public Health 2006, 6:299 http://www.biomedcentral.com/1471-2458/6/299
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